What is CUSIP G30401106?

CUSIP G30401106 is the security identifier used in SEC filing datasets for ENDPQ - Endo International plc - Common Stock, par value $0.001 per share.

Security Snapshot

Endo International plc - Common Stock, par value $0.001 per share (ENDPQ) Institutional Ownership

Q: Who owns ENDPQ - Endo International plc - Common Stock, par value $0.001 per share based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

CUSIP: G30401106

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2023

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period

Security type / class: Equity / Common Stock, par value $0.001 per share
Symbol: ENDPQ
Shares outstanding: 76,364,663

13F Shares, Excluding Options vs Price

13F Value, Excluding Options

Total Investors

Key facts

ENDPQ - Endo International plc - Common Stock, par value $0.001 per share is tracked under CUSIP G30401106.
Latest finished 13F holder period is not available.
1 significant owner is listed from Schedule 13D/13G reporting.

Change

Holder count moved from 1 to 0 between Q1 2023 and Q2 2023.
SEC-reported value moved from $132 to $0.

Research use

You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

G30401106

Latest holder period

n/a

13F holders

13D/G owners

CIK / CUSIP context first

ENDPQ full holder history Endo International plc SEC filings Endo International plc company facts Endo International plc insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP G30401106:

Q2 2023 (0 holders) Q1 2023 (1 holder) Q4 2022 (1 holder) Q3 2022 (8 holders) Q2 2022 (138 holders) Q1 2022 (197 holders) Q4 2021 (198 holders) Q3 2021 (172 holders) Q2 2021 (200 holders) Q1 2021 (185 holders)

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows

Security

ENDPQ

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Oaktree Capital Group Holdings GP, LLC	8%		$61,244		6,124,446		Oaktree Capital Holdings, LLC	31 Dec 2024

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods

Latest

n/a

Rows shown

1-25 of 38

Period	13F Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2023 Q2	0	$0	-$132				0
2023 Q1	1,889	$132				$0.07	1
2022 Q4	1,889	$134	-$192,866			$0.07	1
2022 Q3	2,014,423	$193,000	-$64,293,049	$0	$0	$0.10	8
2022 Q2	139,364,235	$64,893,801	-$50,468,439	$164,937	$117,000	$0.47	138
2022 Q1	193,640,008	$447,392,373	+$10,976,670	$1,883,300	$7,848,000	$2.31	197
2021 Q4	187,653,554	$705,651,621	+$49,602,617	$8,771,120	$14,109,000	$3.76	198
2021 Q3	173,987,551	$563,473,174	-$59,123,453	$15,258,000	$4,227,000	$3.24	172
2021 Q2	189,090,295	$885,014,347	-$15,227,503	$12,910,696	$16,630,000	$4.68	200
2021 Q1	190,682,881	$1,412,874,023	-$21,588,147	$3,760,000	$4,975,000	$7.41	185
2020 Q4	193,516,768	$1,389,332,082	+$48,618,160	$9,949,776	$12,309,000	$7.18	179
2020 Q3	187,868,767	$619,908,815	-$1,868,568	$2,179,000	$2,866,000	$3.30	172
2020 Q2	188,659,857	$647,082,157	-$15,714,814	$6,030,000	$5,428,000	$3.43	190
2020 Q1	192,582,839	$712,078,414	-$54,546,368	$4,368,000	$3,381,000	$3.70	180
2019 Q4	206,044,164	$966,303,944	-$43,943,048	$16,063,000	$18,154,000	$4.69	190
2019 Q3	223,204,350	$716,580,505	-$128,209	$9,604,000	$14,919,000	$3.21	180
2019 Q2	219,643,040	$905,170,250	+$13,928,146	$13,736,000	$15,046,000	$4.12	199
2019 Q1	214,575,588	$1,723,209,289	+$2,116,408	$50,034,000	$34,936,000	$8.03	218
2018 Q4	214,718,674	$1,567,498,531	-$58,706,489	$47,580,000	$30,503,000	$7.30	236
2018 Q3	219,932,446	$3,701,759,047	-$62,043,076	$179,749,000	$166,001,000	$16.83	235
2018 Q2	227,364,303	$2,144,781,710	+$126,910,158	$61,798,000	$53,187,000	$9.43	203
2018 Q1	219,720,155	$1,305,058,120	+$31,810,188	$39,512,000	$8,374,000	$5.94	219
2017 Q4	211,811,266	$1,641,595,977	+$38,916,113	$44,647,000	$13,975,000	$7.75	228
2017 Q3	209,720,863	$1,796,122,630	+$26,541,858	$27,101,000	$21,620,000	$8.56	221
2017 Q2	204,589,624	$2,285,426,810	-$65,288,197	$25,191,000	$63,111,000	$11.17	247